baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Avadel Pharmaceuticals plc/ IE00BDGMC594 /

2024-09-20 9:59:57 PM	Chg. -0.18	Volume	Bid-	Ask-	High	Low
13.41USD	-1.32%	65,509 Turnover: 887,686.53	-Bid Size: -	-Ask Size: -	13.81	13.40

GlobeNewswire 08-28 Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

GlobeNewswire 08-20 Avadel Pharmaceuticals Announces Publication in Clinical Therapeutics of Data Highlighting Weight Lo...

GlobeNewswire 08-08 Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2024 Financial Results

GlobeNewswire 08-01 Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2024 Financial Result...

GlobeNewswire 07-31 Avadel Pharmaceuticals Announces First Patient Dosed in Phase 3 REVITALYZ™ Trial of LUMRYZ™ (sodium ...

GlobeNewswire 06-27 Avadel Pharmaceuticals to Join Russell 3000® Index

GlobeNewswire 05-30 Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

GlobeNewswire 05-22 Avadel Pharmaceuticals Shares New LUMRYZ™ (sodium oxybate) For Extended-release Oral Suspension (CII...

GlobeNewswire 05-21 Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of Directors

GlobeNewswire 05-08 Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial Results

GlobeNewswire 05-01 Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results...

GlobeNewswire 04-01 Avadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference

GlobeNewswire 03-05 Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

GlobeNewswire 03-04 Avadel Pharmaceuticals Issues Statement On Patent Litigation

GlobeNewswire 03-04 Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Finan...

GlobeNewswire 02-26 Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2023 Fi...

GlobeNewswire 01-08 Avadel Pharmaceuticals Announces Strong LUMRYZ Launch Performance and Provides Preliminary Fourth Qu...

GlobeNewswire 2023-11-08 Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results

GlobeNewswire 2023-11-07 Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

GlobeNewswire 2023-10-30 Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter Financial Results on N...

GlobeNewswire 2023-10-20 Avadel Pharmaceuticals Announces Data Supporting Clinical Profile for LUMRYZ™ (sodium oxybate) for e...

GlobeNewswire 2023-10-05 Avadel Pharmaceuticals to Present at the Jefferies Biotech CNS/Neuro Summit

GlobeNewswire 2023-08-31 Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

GlobeNewswire 2022-03-17 Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Finan...

GlobeNewswire 2022-03-14 Avadel Pharmaceuticals Announces Appointment of Brandi Robinson as Senior Vice President, Corporate ...

Avadel Pharmaceuticals plc/ IE00BDGMC594 /

If you wish to receive reply to your feedback, please provide your email address.